Designs for Phase I Clinical Trials with Multiple Courses of Subjects at Different Doses
type: Item
instance of: scholarly article
title: Designs for Phase I Clinical Trials with Multiple Courses of Subjects at Different Doses
zbMATH Open document ID: 1146.62084
author: Shenghua Kelly Fan
author: You-Gan Wang
published in: Biometrics
publication date: 2008-01-14T00:00:00Z
Mathematics Subject Classification ID: 62P10
Mathematics Subject Classification ID: 62G05
Mathematics Subject Classification ID: 62N05
zbMATH DE Number: 5225392
zbMATH Keywords: dose finding
zbMATH Keywords: estimation efficiency
zbMATH Keywords: Fisher information
zbMATH Keywords: isotonic regression
zbMATH Keywords: tables
zbMATH Keywords: toxicity
Wikidata QID: Q44916097
MaRDI profile type: MaRDI publication profile
full work available at URL: j.1541-0420.2007.00772.x
OpenAlex ID: W1968454182
cites work: Optimal Bayesian design applied to logistic regression experiments
cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
cites work: Continual Reassessment Method: A Likelihood Approach
cites work: Non-parametric optimal design in dose finding studies
cites work: Bayesian Design for Dose-Response Curves with Penalized Risk
DOI: 10.1111/J.1541-0420.2007.00772.X
Recommended article: Design and Analysis of Phase I Clinical Trials
Recommended article: Designs for Single- or Multiple-Agent Phase I Trials
Recommended article: The treatment versus experimentation dilemma in dose finding studies
Recommended article: Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
Recommended article: Bayesian optimal designs for phase I clinical trials
description: scientific article; zbMATH DE number 5225392